Sex‐ and tissue‐specific changes in mTOR signaling with age in C57BL/6J mice. Issue 1 (24th November 2015)

• Record Type: Journal Article
• Authors: Baar, Emma L.; Carbajal, Kathryn A.; Ong, Irene M.; Lamming, Dudley W.
• Is Part Of: Aging cell. Volume 15:Issue 1(2016)
• Page Start: 155
• Page End: 166
• Publication Date: 2015-11-24
• Subjects: aging -- mice -- mTOR -- mTORC1 -- mTORC2 -- rapamycin -- sexual dimorphism; Cells -- Aging -- Periodicals; 571.8783605
• DOI: 10.1111/acel.12425
• Languages: English
• ISSNs: 1474-9718

Abstract

Summary: Inhibition of the mTOR (mechanistic Target Of Rapamycin) signaling pathway robustly extends the lifespan of model organisms including mice. The precise molecular mechanisms and physiological effects that underlie the beneficial effects of rapamycin are an exciting area of research. Surprisingly, while some data suggest that mTOR signaling normally increases with age in mice, the effect of age on mTOR signaling has never been comprehensively assessed. Here, we determine the age‐associated changes in mTORC1 (mTOR complex 1) and mTORC2 (mTOR complex 2) signaling in the liver, muscle, adipose, and heart of C57BL/6J.Nia mice, the lifespan of which can be extended by rapamycin treatment. We find that the effect of age on several different readouts of mTORC1 and mTORC2 activity varies by tissue and sex in C57BL/6J.Nia mice. Intriguingly, we observed increased mTORC1 activity in the liver and heart tissue of young female mice compared to male mice of the same age. Tissue and substrate‐specific results were observed in the livers of HET3 and DBA/2 mouse strains, and in liver, muscle and adipose tissue of F344 rats. Our results demonstrate that aging does not result in increased mTOR signaling in most tissues and suggest that rapamycin does not promote lifespan by reversing or blunting such an effect.